中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
Author:( Luyao QIAN)

1.Cross-talk of GPCRs and RTKs and its effects on oncotherapy

Luyao CHEN ; Yang YANG ; Shu AN ; Xiaoxi GUO ; Qian HAO ; Tianrui XU ; Ying LIU

Chinese Pharmacological Bulletin 2017;33(4):454-460

2.Analysis of factors causing complications in CT-guided percutaneous lung biopsy with 18 G-Bard Magnum needle

Baohua JIANG ; Jin ZHANG ; Yunhai HUANG ; Luyao QIAN ; Tiechen XIAO ; Xing LI

Journal of Interventional Radiology 2015;(9):792-796

3.Discussion on the validity period determination method of commercial ready-to-use TSA medium

Wenyue KOU ; Yuru JIANG ; Luyao HAO ; Yuyi TANG ; Xueyun ZHOU ; Xiujuan ZHU ; Zhen QIAN ; Ge JIN ; Jiaojiao WANG

Drug Standards of China 2024;25(3):289-295

4.The efficacy and safety of protein A immunoadsorption combined with rituximab treatment for highly sensitized patients undergoing haplo-hematopoietic stem cell transplantation

Ling LI ; Wenjuan ZHU ; Qian ZHU ; Shiyuan ZHOU ; Chao MA ; Jun WANG ; Xiaohui HU ; Yue HAN ; Ying WANG ; Xiaowen TANG ; Xiao MA ; Suning CHEN ; Huiying QIU ; Luyao CHEN ; Jun HE ; Depei WU ; Xiaojin WU

Chinese Journal of Hematology 2024;45(5):468-474

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO